<div class="tables frame-topbot colsep-0 rowsep-0" id="tbl1">
<div class="captions"><span id="cap0055"><p id="tspara0010"><span class="label">Table 1</span>. Outcomes of NSAID Use Versus Never Used NSAID in RE-LY<a name="btbl1fnlowast" href="#tbl1fnlowast" class="workspace-trigger"><sup>∗</sup></a></p></span></div>
<div class="groups"><table>
<thead><tr class="rowsep-1 valign-top">
<th scope="col"></th>
<th scope="col">NSAID</th>
<th scope="col">No NSAID</th>
<th scope="col">HR (95% CI)</th>
<th scope="col">p Value<a name="btbl1fndagger" href="#tbl1fndagger" class="workspace-trigger">†</a>
</th>
</tr></thead>
<tbody>
<tr class="valign-top">
<td>Patient-yrs</td>
<td class="align-center">4,584</td>
<td class="align-center">31,143</td>
<td></td>
<td></td>
</tr>
<tr class="valign-top">
<td>Major bleeding</td>
<td class="align-center">206 (4.5)</td>
<td class="align-center">976 (3.1)</td>
<td class="align-center">1.39 (1.20−1.63)</td>
<td class="align-char">&lt;0.0001</td>
</tr>
<tr class="valign-top">
<td>GI major bleeding</td>
<td class="align-center">83 (1.8)</td>
<td class="align-center">371 (1.2)</td>
<td class="align-center">1.48 (1.16−1.89)</td>
<td class="align-char">0.0018</td>
</tr>
<tr class="valign-top">
<td>ICH</td>
<td class="align-center">24 (0.5)</td>
<td class="align-center">133 (0.4)</td>
<td class="align-center">1.20 (0.77−1.86)</td>
<td class="align-char">0.42</td>
</tr>
<tr class="valign-top">
<td>Any bleeding</td>
<td class="align-center">1,045 (22.8)</td>
<td class="align-center">4,880 (15.7)</td>
<td class="align-center">1.60 (1.50−1.71)</td>
<td class="align-char">&lt;0.0001</td>
</tr>
<tr class="valign-top">
<td>Stroke/SE</td>
<td class="align-center">81 (1.8)</td>
<td class="align-center">440 (1.4)</td>
<td class="align-center">1.27 (0.99−1.61)</td>
<td class="align-char">0.0553</td>
</tr>
<tr class="valign-top">
<td>Ischemic stroke</td>
<td class="align-center">61 (1.3)</td>
<td class="align-center">329 (1.1)</td>
<td class="align-center">1.27 (0.96−1.67)</td>
<td class="align-char">0.10</td>
</tr>
<tr class="valign-top">
<td>Hemorrhagic stroke</td>
<td class="align-center">11 (0.2)</td>
<td class="align-center">60 (0.2)</td>
<td class="align-center">1.22 (0.64−2.35)</td>
<td class="align-char">0.54</td>
</tr>
<tr class="valign-top">
<td>SE</td>
<td class="align-center">12 (0.3)</td>
<td class="align-center">37 (0.1)</td>
<td class="align-center">2.31 (1.19−4.47)</td>
<td class="align-char">0.01</td>
</tr>
<tr class="valign-top">
<td>Myocardial infarction</td>
<td class="align-center">32 (0.7)</td>
<td class="align-center">210 (0.7)</td>
<td class="align-center">1.07 (0.73−1.57)</td>
<td class="align-char">0.73</td>
</tr>
<tr class="valign-top">
<td>Hospitalization</td>
<td class="align-center">1,152 (25.1)</td>
<td class="align-center">6,048 (19.4)</td>
<td class="align-center">1.41 (1.32−1.50)</td>
<td class="align-char">&lt;0.0001</td>
</tr>
<tr class="valign-top">
<td>All-cause mortality</td>
<td class="align-center">161 (3.5)</td>
<td class="align-center">1,210 (3.9)</td>
<td class="align-center">0.88 (0.75−1.05)</td>
<td class="align-char">0.15</td>
</tr>
</tbody>
</table></div>
<p class="legend"></p>
<p id="tspara0015">Values are n (% per year) unless otherwise indicated.</p>
<p id="tspara0020">b.i.d. = twice
 a day; CI = confidence interval; 
GI = gastrointestinal; HR = hazard ratio; 
ICH = intracranial hemorrhage; NSAID = nonsteroidal 
anti-inflammatory drug; RE-LY = Randomized Evaluation of Long Term 
Anticoagulant Therapy; SE = systemic embolism.</p>
<dl class="footnotes">
<dt id="tbl1fnlowast">∗</dt>
<dd><p id="ntpara0015">Treatment independent (dabigatran 110 mg b.i.d., dabigatran 150 mg b.i.d., or warfarin).</p></dd>
<dt id="tbl1fndagger">†</dt>
<dd><p id="ntpara0020">HRs
 and p values calculated using Cox regression model and multivariate 
adjusted analysis. Multivariate analysis adjusted for: continuous 
variables: age, body mass index, and creatinine clearance; and discrete 
variables: sex, type of atrial fibrillation, history of heart failure, 
hypertension, previous stroke, coronary artery disease, previous 
myocardial infarction, diabetes mellitus, valvular heart disease, and 
baseline medication: proton-pump inhibitor, beta-blocker, statin, 
aspirin/clopidogrel/dipyridamole, and angiotensin-converting enzyme 
inhibitor/angiotensin receptor blocker.</p></dd>
</dl>
</div>
